1. Six-month respiratory outcomes and exercise capacity of COVID-19 acute respiratory failure patients treated with continuous positive airway pressure.
- Author
-
Damanti, Sarah, Ramirez, Giuseppe Alvise, Bozzolo, Enrica Paola, Rovere-Querini, Patrizia, De Lorenzo, Rebecca, Magnaghi, Cristiano, Scotti, Raffaella, Di Lucca, Giuseppe, Marinosci, Alessandro, Strada, Silvia, Di Terlizzi, Gaetano, Vitali, Giordano, Martinenghi, Sabina, Compagnone, Nicola, Landoni, Giovanni, and Tresoldi, Moreno
- Subjects
RESPIRATORY insufficiency ,COVID-19 ,EXERCISE tolerance ,SCIENTIFIC observation ,CONTINUOUS positive airway pressure ,RETROSPECTIVE studies ,TREATMENT effectiveness ,HOSPITAL care ,QUESTIONNAIRES ,DESCRIPTIVE statistics ,ACUTE diseases - Abstract
Background: COVID-19 long-term sequelae are ill-defined since only a few studies have explored the long-term consequences of this disease so far. Aims: To evaluate the 6-month respiratory outcome and exercise capacity of COVID-19 acute respiratory failure (ARF) patients treated with continuous positive airway pressure (CPAP) during the first wave of the ongoing COVID-19 pandemic. Methods: A retrospective observational study included COVID-19 patients with ARF. Interventions included CPAP during hospitalisation and 6-month follow up. Frailty assessment was carried out through frailty index (FI), pO
2 /FiO2 during hospitalisation and at follow up, respiratory parameters, 6-min walking test (6MWT) and the modified British Medical Research Council (mMRC) and Borg scale at follow up. Results: More than half of the patients had no dyspnoea according to the mMRC scale. Lower in-hospital pO2 /FiO2 correlated with higher Borg scale levels after 6MWT (- 0.27; P 0.04) at the follow-up visit. FI was positively correlated with length of hospitalisation (- 0.3; P 0.03) and negatively with the 6MWT distance walked (- 0.36; P 0.004). Conclusions: Robust and frail patients with COVID-19 ARF treated with CPAP outside the intensive care unit setting had good respiratory parameters and exercise capacity at 6-month follow up, although more severe patients had slightly poorer respiratory performance compared with patients with higher PaO2 /FiO2 and lower FI. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF